<DOC>
	<DOCNO>NCT01961713</DOCNO>
	<brief_summary>This study evaluate method detect tumor cell circulate blood without get biopsy . The investigator already know study cancer tumor shed small number cell bloodstream every day . These call circulating tumor cell ( CTCs ) . Some early study indicate amount type CTCs blood help determine status tumor way respond treatment . In study , investigator compare number CTCs blood different time frame surgery remove prostate .</brief_summary>
	<brief_title>Circulating Tumor Cell Analysis Patients With Localized Prostate Cancer Undergoing Prostatectomy</brief_title>
	<detailed_description>The investigator collect blood sample study participant blood test draw cancer treatment . The investigator take one sample check prostate specific antigen ( PSA ) level another blood sample CTC analysis . The investigator draw blood follow time point : Screening ; One day surgery ; 7-14 day surgery ; 3-6 month surgery ; PSA recurrence two year .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<criteria>Male 18 year age old Pathologically confirm diagnosis prostate adenocarcinoma Nonmetastatic prostate cancer Planned radical prostatectomy Massachusetts General Hospital Patients must receive prior radiation therapy , hormone therapy , medical therapy prostate cancer prior prostatectomy . Postprostatectomy therapy discretion patient 's treating physician ( ) allow . Patients must metastatic prostate cancer No prior current diagnosis epithelial malignancy , except skin cancer ( squamous cell carcinoma basal cell carcinoma )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>circulate tumor cell</keyword>
	<keyword>CTC-Chip</keyword>
</DOC>